About 300 mg Abamune Abacavir Tablets
Abamune 300 mg Abacavir Tablets, manufactured by ace pharmaceutical Cipla Ltd., offer first-string antiretroviral therapy for adults and adolescents with HIV-1 infection. Each capsule-shaped, white tablet delivers 300 mg of Abacavir Sulphate, ensuring reliable, prescription-only medication under India's stringent regulatory standards. With a life span of 24 months and astonishingly competitive pricing, Abamune guarantees optimal market value and accessibility. The product comes in bottles of 30 tablets, is recommended as combination therapy, and requires proper screening for hypersensitivity before administration. Order now for trusted quality and efficacy.
Competitive Edge and First-string HIV Treatment
Abamune 300 mg Abacavir Tablets stand out for their competitive pricing and ace efficacy in combination antiretroviral therapy. Specifically tailored for oral administration, these tablets ensure effective systemic delivery of Abacavir. Suited for adults and adolescents, the tablet format ensures convenient dosage control and compliance. Administered as part of a supervised regimen, Abamune's site of application is oral, making it simple to integrate into daily routines for optimum patient outcomes.
Supply Ability and Market Value
Abamune 300 mg is backed by robust transport services and secure goods transport, assuring reliable supply and swift fulfillment across the main domestic market in India. Each order is processed by a first-string network of exporters, manufacturers, and suppliers, guaranteeing consistent availability. Payment terms are flexible and competitive, reinforcing the market value of Abamune. With a strong distribution backbone, clients gain access to timely deliveries and exceptional post-sale support.
FAQ's of 300 mg Abamune Abacavir Tablets:
Q: How should Abamune 300 mg Abacavir Tablets be administered?
A: Abamune 300 mg tablets are to be taken orally, strictly as directed by a physician. It is essential to follow the prescribed dosage and schedule to ensure optimal therapeutic outcomes.
Q: What are the main competitive advantages of Abamune 300 mg tablets?
A: Abamune offers competitive pricing, approved quality from Cipla Ltd., convenient packaging, and enhanced accessibility within India, making it a first-string choice for HIV-1 combination therapy.
Q: When should screening for HLA-B*5701 allele be considered before starting Abamune?
A: Screening for the HLA-B*5701 allele is strongly recommended before initiating Abamune treatment to minimize the risk of hypersensitivity reactions associated with Abacavir.
Q: Where can Abamune 300 mg tablets be obtained in India?
A: Abamune 300 mg is available through prescription from authorized pharmacies, exporters, suppliers, and traders who operate within India's regulated pharmaceutical framework.
Q: What is the process for storing Abamune 300 mg Abacavir Tablets?
A: These tablets should be stored below 30C, protected from light and moisture, and kept in their original bottle to preserve potency throughout their 24-month shelf life.
Q: What are the common side effects of using Abamune 300 mg tablets?
A: Common side effects include nausea, headache, fatigue, vomiting, and rash. Patients should consult their physician immediately if severe or persistent adverse reactions occur.